Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel diseaseComment Published on 2023-04-012023-07-09 Journal: Gut [Category] COVID19(2023년), [키워드] COVID-19 Crohn's disease ulcerative colitis. [DOI] 10.1136/gutjnl-2022-327440 PMC 바로가기 [Article Type] Comment
Hepatitis E infection with a benign course during vedolizumab treatment for Crohn’s disease: A case reportCase Reports Published on 2022-08-012023-06-11 Journal: Clinics and research in hepatology and gastroenter [Category] E형 간염, [키워드] Crohn's disease hepatitis E IBD vedolizumab. [DOI] 10.1016/j.clinre.2022.101948 PMC 바로가기 [Article Type] Case Reports
Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study염증성 장질환이나 면역억제제는 심각한 COVID-19의 위험 증가와 관련이 없습니다: 관찰 네덜란드 코호트 연구Observational Study Published on 2022-08-012022-09-11 Journal: Clinical and experimental medicine [Category] SARS, 임상, 치료기술, [키워드] 95% confidence interval Admission affected Biological bowel Characteristics children clinical Cohort cohort characteristics cohort study Comorbidity COVID-19 COVID-19 case COVID-19 cases Crohn's disease Deceased determinant died disease examined Follow-up General population had no healthcare healthcare providers Hospital admission Hospitalized IBD ICD-10 Immunosuppressant immunosuppressants Immunotherapy increased risk Inflammatory bowel disease intensive care medication Mortality National observational study occurred Older outbreak Patient patients regions Respiratory Support Result retrospective risk factor Risk factors SARS-CoV-2 Seven severe COVID-19 significantly more the SARS-CoV-2 Thiopurine. Treatment was performed women [DOI] 10.1007/s10238-021-00755-3 PMC 바로가기 [Article Type] Observational Study
Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease종양 괴사 인자-α 길항제의 사용은 염증성 장 질환이 있는 백신 접종 환자에서 SARS-CoV-2에 대한 약화된 IgG 항체 반응과 관련이 있습니다Observational Study Published on 2022-07-052022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, [키워드] Against age antagonist antagonists anti-SARS-CoV-2 antibody anti-SARS-CoV-2 vaccination antibody Antibody concentrations Antibody titer Antibody titers Biologicals Blood blood sampling bowel Characteristics clinical Clinical characteristics Combination completion Concentration COVID-19 Crohn's disease defined demonstrated detectable disease Effect elapsed geometric geometric mean IBD IgG IgG antibodies IgG antibody IgG antibody titer IgG antibody titers immune response immunoassay immunomodulating Immunosuppressive medication immunosuppressive medications increased risk independent independent of Inflammatory Inflammatory bowel disease medication Microparticle monotherapy Most patients mRNA mRNA vaccines mRNA-based vaccine mRNA-based vaccines Multivariable models Patient patient age patients patients treated prospective observational cohort quantitative determination RBD receive receiving Receptor-binding domain regimen response S1 subunit sampling SARS-CoV-2 SARS-COV-2 infection Seroconversion serological response significantly lower Spike protein the receptor-binding domain the S1 subunit the spike protein titer TNF-α-antagonists treated Treatment Tumor ulcerative colitis vaccination vaccination. Vaccine vector was used were measured were recorded [DOI] 10.3389/fimmu.2022.920333 PMC 바로가기 [Article Type] Observational Study
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic임상 실습의 최근 발전: COVID-19 대유행 중 염증성 장 질환 관리Review Published on 2022-07-012022-09-11 Journal: Gut [Category] COVID19(2023년), SARS, 치료기술, [키워드] acquisition adverse outcome adverse outcomes antibody booster dose bowel Breakthrough infection breakthrough infections Cancer cancers Corticosteroid Corticosteroids COVID-19 COVID-19 in patient COVID-19 pandemic Crohn's disease de novo decrease develop diagnoses disease course dose Evidence Future General population Guidance hospitalisation hospitalisations Humoral response humoral responses IBD immune immune response immunosuppressive therapies immunosuppressive therapy increased risk Inflammatory Inflammatory bowel disease management medication medications Necrosis outcome outcomes pandemic Patient patients potential risk primary dose raised receive recent remained Research risk risk of COVID-19 SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines TNF treated Treatment ulcerative ulcerative colitis Vaccine vaccine response vaccine. Vaccines [DOI] 10.1136/gutjnl-2021-326784 PMC 바로가기 [Article Type] Review
Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease염증성 장 질환이 있는 소아 및 젊은 성인의 감염 또는 예방 접종 후 SARS-CoV-2에 대한 항체 반응Article Published on 2022-07-012022-09-11 Journal: Inflammatory bowel diseases [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] ACE2 age angiotensin Antibody Response approved binding domain biologic biologic therapies Cell characterization children clinical symptom Cohort Crohn's disease disease dynamic range embryonic kidney enrolled enzyme expressing flow cytometry fluorescent HEK-293 Hospitalized IBD IgG antibodies IgG antibody IgG positivity IgG response immunization immunoassay Inflammatory bowel disease infliximab lentivirus less longitudinal cohort study measure Most patients natural infection neutralization antibodies Neutralization antibody Neutralization assay Neutralizing antibodies neutralizing antibody Patient PCR Pediatric patient performed post infection Protective Protein binding RBD IgG receiving Receptor binding domain Reinfection response risk robust S-RBD SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike protein SARS-CoV-2 spike protein receptor binding domain serum significantly lower Spike protein subject the spike protein therapy ulcerative colitis vaccination Vaccines variant vedolizumab was used wild type [DOI] 10.1093/ibd/izab207 PMC 바로가기 [Article Type] Article
Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence염증성 장 질환 환자의 코로나19 백신에 대한 SARS-CoV-2 감염 및 면역 반응의 위험: 현재 증거Review Published on 2022-06-232022-09-11 Journal: Frontiers in Immunology [Category] 변종, [키워드] aberrant immune response Affect available data bowel Combination condition Corticosteroid Corticosteroids Course COVID-19 COVID-19 vaccine COVID-19 vaccines Crohn's disease Crohn’s disease current disease dysregulated environmental factors Factor forms healthy subjects IBD immune immune response immunogenicity Immunosuppressant immunosuppressants increased risk infection with SARS-CoV-2 infections Inflammatory Inflammatory bowel disease inflammatory bowel diseases intestinal intestinal disease less majority many case many cases measure modify Necrosis occur pandemic Pathogens Patient patients treated PROTECT Psychological psychological factors question receive reduce reduced response risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants significantly increased subject susceptibility susceptibility to infection susceptible individual therapy ulcerative colitis ulcerative colitis. Vaccine [DOI] 10.3389/fimmu.2022.933774 PMC 바로가기 [Article Type] Review
Sonic hedgehog pathway for the treatment of inflammatory diseases: implications and opportunities for future research염증성 질환 치료를 위한 음파 고슴도치 경로: 향후 연구를 위한 의미 및 기회Editorial Published on 2022-06-012022-09-11 Journal: Journal for immunotherapy of cancer [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] Activation acute myeloid leukemia Airway inflammation allergy Arthritis Asthma atopic dermatitis Autoimmune diseases Basal cell basal cell carcinoma Breast cancer Cancer cancer development cancers Cell cellular response component conserved COVID-19 Crohn's disease different diseases disease drugs dysregulation embryogenesis Factors glioma homolog Host human body immune dysregulation immune response immune system evasion implication Infection infections Inflammation Inflammation Mediators. Inflammatory Influenza inhibit investigated involved lung carcinoma malignancies mechanism medulloblastoma Mutation Pancreatic cancer pathogen pathogen-mediated pathogenic pathway progression receptor receptor inhibitor Research rheumatoid arthritis SARS-CoV-2 viruses shifting signaling pathway targets Therapeutic approach therapeutic strategy tissue homeostasis transcriptional treat Treatment tumors [DOI] 10.1136/jitc-2021-004397 PMC 바로가기 [Article Type] Editorial
Mycobacterium paratuberculosis zoonosis is a One Health emergencyReview Published on 2022-06-012023-06-22 Journal: EcoHealth [Category] 조류인플루엔자, [키워드] autoimmune diabetes Crohn's disease Johne's disease Mycobacterium avium ss. paratuberculosis one health zoonosis. [DOI] 10.1007/s10393-022-01602-x PMC 바로가기 [Article Type] Review
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysisReview Published on 2022-06-012023-07-08 Journal: Digestive and liver disease : official journal of [Category] COVID19(2023년), [키워드] Crohn's disease SARS-CoV-2 Side-effect ulcerative colitis. [DOI] 10.1016/j.dld.2022.03.005 PMC 바로가기 [Article Type] Review